Citations

Mayo Clinic

Showing 10 of 108522 citations.

Erratum for Tesfay et al., PEGylation of Vesicular Stomatitis Virus Extends Virus Persistence in Blood Circulation of Passively Immunized Mice
Tesfay, Mulu Z. , Kirk, Amber C., Hadac, Elizabeth M., Griesmann, Guy E., Federspiel, Mark J. , Barber, Glen N. , Henry, Stephen , Peng, Kah-Whye , Russell, Stephen J. , Russell, Stephen J

Journal of Virology | January 26, 2015 | Volume: 89 | Issue: 4 | Pages: 2453-2453

10.1128/jvi.03446-14 Get It

Was a decision made? An assessment of patient–clinician discordance in medical oncology encounters
Leppin, Aaron L. , Humeniuk, Katherine M., Fernandez, Cara, Montori, Víctor M. , Yost, Kathleen J. , Kumbamu, Ashok , Geller, Gail , Tilburt, Jon C. , Yost, Kathleen, Montori, Victor M

Health Expectations | January 26, 2015 | Volume: 18 | Issue: 6 | Pages: 3374-3381

10.1111/hex.12340 | PMID 25619877 Get It

AbstractBackgroundShared decision making is promoted to improve cancer care quality. Patients and clinicians may have different ideas about what constitutes a cancer care decision, which may limit the validity of self‐reported measures of shared decision making. We sought to estimate the extent to which patients and clinicians agree on whether a cancer care decision was made during an outpatient encounter.MethodsWe surveyed patients and clinicians immediately after an oncology encounter at a large, tertiary medical centre and calculated agreement in response to the single‐item question, ‘Was a specific decision about cancer care made during the appointment today?’ Answer options were ‘yes’ and ‘no’. Participants were 315 oncology patients, with any solid tumour malignancy and at any stage of management, and their clinicians (22 staff oncologists, nine senior fellows and five nurse practitioners).ResultsPatients and clinicians reported having made a cancer care decision in 184 (58%) and 174 (55%) of encounters, respectively. They agreed on whether a cancer care decision was made in 213 (68%) of encounters (chance‐adjusted agreement was 0.34); in 56 of the 102 discordant encounters, the patient reported making a decision while the clinician did not. We found no significant correlates with discordance.ConclusionsPatients and clinicians do not always agree on whether a cancer care decision was made. As such, measures that ask patients and/or clinicians to evaluate a decision‐making process or outcome may be methodologically insufficient when they do not explicitly orient respondents towards the thing they are being asked to assess.
Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
Beach, Thomas G. , Sue, Lucia I., Shill, Holly A. , Walker, Douglas G. , Lue, Lih‐Fen , Roher, Alex E., Dugger, Brittany N. , Maarouf, Chera L., Birdsill, Alex C. , Intorcia, Anthony J., Saxon‐LaBelle, Megan, Pullen, Joel, Scroggins, Alexander, Filon, Jessica, Scott, Sarah, Hoffman, Brittany, Garcia, Angelica, Caviness, John N., Hentz, Joseph G. , Driver‐Dunckley, Erika , Jacobson, Sandra A. , Davis, Kathryn, Belden, Christine M. , Long, Kathy E., Malek‐Ahmadi, Michael , Powell, Jessica, Gale, Lisa D., Nicholson, Lisa R., Caselli, Richard J. , Woodruff, Bryan K. , Rapscak, Steven Z., Ahern, Geoffrey L., Shi, Jiong , Burke, Anna , Reiman, Eric M. , Sabbagh, Marwan N. , Driver-Dunckley, Erika, Adler, Charles H. , Serrano, Geidy E. , Scroggins, Alex, Dugger, Brittany N

Neuropathology | January 26, 2015 | Volume: 35 | Issue: 4 | Pages: 354-389

10.1111/neup.12189 | PMID 25619230 Get It

The Brain and Body Donation Program (BBDP) at Banner Sun Health Research Institute (http://www.brainandbodydonationprogram.org) started in 1987 with brain‐only donations and currently has banked more than 1600 brains. More than 430 whole‐body donations have been received since this service was commenced in 2005. The collective academic output of the BBDP is now described as the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND). Most BBDP subjects are enrolled as cognitively normal volunteers residing in the retirement communities of metropolitan Phoenix, Arizona. Specific recruitment efforts are also directed at subjects with Alzheimer's disease, Parkinson's disease and cancer. The median age at death is 82. Subjects receive standardized general medical, neurological, neuropsychological and movement disorders assessments during life and more than 90% receive full pathological examinations by medically licensed pathologists after death. The Program has been funded through a combination of internal, federal and state of Arizona grants as well as user fees and pharmaceutical industry collaborations. Subsets of the Program are utilized by the US National Institute on Aging Arizona Alzheimer's Disease Core Center and the US National Institute of Neurological Disorders and Stroke National Brain and Tissue Resource for Parkinson's Disease and Related Disorders. Substantial funding has also been received from the Michael J. Fox Foundation for Parkinson's Research. The Program has made rapid autopsy a priority, with a 3.0‐hour median post‐mortem interval for the entire collection. The median RNA Integrity Number (RIN) for frozen brain and body tissue is 8.9 and 7.4, respectively. More than 2500 tissue requests have been served and currently about 200 are served annually. These requests have been made by more than 400 investigators located in 32 US states and 15 countries. Tissue from the BBDP has contributed to more than 350 publications and more than 200 grant‐funded projects.
Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations
Mir, Muhammad A. , Kochuparambil, Samith T. , Abraham, Roshini S. , Rodriguez, Vilmarie , Howard, Matthew H., Jackson, Amie E., Holland, Steven M. , Patnaik, Mrinal M. , Hsu, Amy P.

Cancer Medicine | January 26, 2015 | Volume: 4 | Issue: 4 | Pages: 490-499

10.1002/cam4.384 | PMID 25619630 Get It

AbstractGuanine‐adenine‐thymine‐adenine 2 (GATA2) mutated disorders include the recently described MonoMAC syndrome (Monocytopenia and Mycobacterium avium complex infections), DCML (dendritic cell, monocyte, and lymphocyte deficiency), familial MDS/AML (myelodysplastic syndrome/acute myeloid leukemia) (myeloid neoplasms), congenital neutropenia, congenital lymphedema (Emberger's syndrome), sensorineural deafness, viral warts, and a spectrum of aggressive infections seen across all age groups. While considerable efforts have been made to identify the mutations that characterize this disorder, pathogenesis remains a work in progress with less than 100 patients described in current literature. Varying clinical presentations offer diagnostic challenges. Allogeneic stem cell transplant remains the treatment of choice. Morbidity, mortality, and social costs due to the familial nature of the disease are considerable. We describe our experience with the disorder in three affected families and a comprehensive review of current literature.
The role of hemodynamic catheterization in the evaluation of hypertrophic obstructive cardiomyopathy: A case series
Bishu, Kalkidan, Coylewright, Megan , Nishimura, Rick, Nishimura, Rick A.

Catheterization and Cardiovascular Interventions | January 24, 2015 | Volume: 86 | Issue: 5 | Pages: 903-912

10.1002/ccd.25856 | PMID 25620326 Get It

Confirmation of the presence and magnitude of left ventricular outflow tract (LVOT) obstruction is a critical component of the evaluation of symptoms in patients with hypertrophic cardiomyopathy (HCM). The presence of LVOT obstruction in patients with severe symptoms refractory to pharmacologic therapy identifies a subgroup of HCM patients who may benefit from septal reduction therapy. Two‐dimensional echocardiography with continuous wave Doppler is the main tool for confirming the presence and severity of LVOT obstruction in HCM. However, when uncertainty remains following non‐invasive evaluation, invasive hemodynamics studies are required to confirm and quantify LVOT obstruction. In this manuscript we describe a series of 6 cases in which hemodynamic catheterization is instrumental in supplementing non‐invasive imaging in the assessment of LVOT obstruction in HCM. © 2015 Wiley Periodicals, Inc.
Reply to reflection on MUNE
Gooch, Clifton L. , Doherty, Timothy J., Chan, K. Ming , Bromberg, Mark B. , Lewis, Richard A. , Stashuk, Dan, Berger, Michael , Andary, Michael , Daube, Jasper R.

Muscle & Nerve | January 24, 2015 | Volume: 51 | Issue: 4 | Pages: 624-624

10.1002/mus.24585 | PMID 25620429 Get It

Intervention to Reduce Inappropriate Ionized Calcium Ordering Practices: A Quality-Improvement Project
Newman, Darrell B. , Siontis, Konstantinos C. , Chandrasekaran, Krishnaswamy , Jaffe, Allan S. , Kashiwagi, Deanne T. , Jaffe, Allan S.

The Permanente Journal | January 23, 2015 | Volume: 19 | Issue: 1 | Pages: 49-51

10.7812/tpp/14-108 | PMID 25663205 Get It

JOURNAL CLUB: Molecular Breast Imaging at Reduced Radiation Dose for Supplemental Screening in Mammographically Dense Breasts
Rhodes, Deborah J. , Conners, Amy Lynn , Tortorelli, Cindy L., Maxwell, Robert W. , Jones, Katie N., Toledano, Alicia Y. , O’Connor, Michael K. , Hruska, Carrie B.

American Journal of Roentgenology | January 23, 2015 | Volume: 204 | Issue: 2 | Pages: 241-251

10.2214/ajr.14.13357 | PMID 25615744 Get It

Emerging Role of Cardiovascular CT and MRI in the Evaluation of Stroke
Pagán, Ricardo J. , Parikh, Pragnesh , Mergo, Patricia J. , Gerber, Thomas C., Mankad, Rekha , Freeman, William D. , Shapiro, Brian P. , Freeman, William D , Mankad, Rekha

American Journal of Roentgenology | January 23, 2015 | Volume: 204 | Issue: 2 | Pages: 269-280

10.2214/ajr.14.13051 | PMID 25615749 Get It